Pharmaceutical Manufacturing Handbook: Production and

806 TRANSDERMAL DRUG DELIVERY
19. El - Kattan , A. F. , Asbill , C. S. , and Michniak , B. B. ( 2000 ), The effect of terpene enhancer
lipophilicity on the percutaneous permeation of hydrocortisone formulated in HPMC gel
systems , Int. J. Pharm ., 198 ( 2 ), 179 – 189 .
20. Krishnaiah , Y. S. , and Bhaskar , P. ( 2004 ), Studies on the transdermal delivery of
nimodipine from a menthol - based TTS in human volunteers , Curr. Drug Deliv ., 1 ( 2 ),
93 – 102 .
21. Misra , A. , et al . ( 1997 ), Biphasic testosterone delivery profi le observed with two different
transdermal formulations , Pharm. Res ., 14 ( 9 ), 1264 – 1268 .
22. Burkman , R. T. ( 2004 ), The transdermal contraceptive system , Am. J. Obstet. Gynecol .,
190 ( 4 , Suppl), S49 – 53 .
23. Sane , N. , and McGough , J. J. ( 2002 ), MethyPatch Noven , Curr. Opin. Invest. Drugs , 3 ( 8 ),
1222 – 1224 .
24. Amsterdam , J. D. ( 2003 ), A double - blind, placebo - controlled trial of the safety and effi -
cacy of selegiline transdermal system without dietary restrictions in patients with major
depressive disorder , J. Clin. Psychiatry , 64 ( 2 ), 208 – 214 .
25. Chien , Y. W. ( 1985 ), Microsealed drug delivery systems: Fabrications and performance ,
Methods Enzymol ., 112 , 461 – 470 .
26. Parrott , A. C. ( 1989 ), Transdermal scopolamine: A review of its effects upon motion sickness,
psychological performance, and physiological functioning , Aviat. Space Environ.
Med ., 60 ( 1 ), 1 – 9 .
27. Burris , J. F. , and Mroczek , W. J. ( 1986 ), Transdermal administration of clonidine: A new
approach to antihypertensive therapy , Pharmacotherapy , 6 ( 1 ), 30 – 34 .
28. Trommer , H. , and Neubert , R. H. ( 2006 ), Overcoming the stratum corneum: The modulation
of skin penetration. A review , Skin Pharmacol. Physiol ., 19 ( 2 ), 106 – 121 .
29. Xu , P. , and Chien , Y. W. ( 1991 ), Enhanced skin permeability for transdermal drug delivery:
Physiopathological and physicochemical considerations , Crit. Rev. Ther. Drug Carrier
Syst ., 8 ( 3 ), 211 – 236 .
30. Williams , A. C. , and Barry , B. W. ( 1991 ), Terpenes and the lipid - protein - partitioning theory
of skin penetration enhancement , Pharm. Res ., 8 ( 1 ), 17 – 24 .
31. Henry , S. , et al . ( 1998 ), Microfabricated microneedles: A novel approach to transdermal
drug delivery , J. Pharm. Sci ., 87 ( 8 ), 922 – 925 .
32. Giudice , E. L. , and Campbell , J. D. ( 2006 ), Needle - free vaccine delivery , Adv. Drug Del.
Rev ., 58 ( 1 ), 68 – 89 .
33. Aqil , M. , Sultana , Y. , and Ali , A. ( 2006 ), Transdermal delivery of beta - blockers , Expert
Opin. Drug Deliv , 3 ( 3 ), 405 – 418 .
34. Cormier , M. , et al . ( 2004 ), Transdermal delivery of desmopressin using a coated microneedle
array patch system , J. Controlled Release , 97 ( 3 ), 503 – 511 .
35. Fischer , G. A. ( 2005 ), Iontophoretic drug delivery using the IOMED Phoresor system ,
Expert Opin. Drug Deliv ., 2 ( 2 ), 391 – 403 .
36. Parad , R. B. , et al . ( 2005 ), Sweat testing infants detected by cystic fi brosis newborn screening
, J. Pediatr ., 147 ( 3, Suppl ), S69 – 72 .
37. Miaskowski , C. ( 2005 ), Patient - controlled modalities for acute postoperative pain management
, J. Perianesth. Nurs ., 20 ( 4 ), 255 – 267 .
38. Sinatra , R. ( 2005 ), The fentanyl HCl patient - controlled transdermal system (PCTS): An
alternative to intravenous patient - controlled analgesia in the postoperative setting , Clin.
Pharmacokinet ., 44 ( Suppl 1 ), 1 – 6 .
39. Mitragotri , S. , and Kost , J. ( 2000 ), Low - frequency sonophoresis: A noninvasive method
of drug delivery and diagnostics , Biotechnol. Prog ., 16 ( 3 ), 488 – 492 .